JAC Advance Access originally published online on November 28, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Journal of Antimicrobial Chemotherapy (2003) 51, 69-76
© 2003 The British Society for Antimicrobial Chemotherapy
An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECO·SENS Project
Department of Clinical Microbiology, Central Hospital, SE-351 85 Växjö, Sweden
Received 11 March 2002; returned 20 June 2002; revised 10 August 2002; accepted 3 October 2002
The ECO·SENS study is the first international survey to investigate the prevalence and susceptibility of pathogens causing community-acquired acute uncomplicated urinary tract infections (UTIs). Midstream urine samples were taken for culture and for testing for the presence of leucocytes from 4734 women not older than 65 years presenting with symptoms of acute UTI at 252 community health care centres in 17 countries. Recognized urinary tract pathogens were identified and the susceptibility to 12 antimicrobials determined. Pathogens were present in 3278 (69.2%) patients, Escherichia coli accounting for 77.0% of isolates. In E. coli, 42% of the isolates were resistant to one or more of the 12 antimicrobial drugs investigated. Resistance was most common to ampicillin (29.8%) and sulfamethoxazole (29.1%), followed by trimethoprim (14.8%), trimethoprim/sulfamethoxazole (14.1%) and nalidixic acid (5.4%). Resistance in E. coli to co-amoxiclav, mecillinam, cefadroxil, nitrofurantoin, fosfomycin, gentamicin and ciprofloxacin was <3%. However, co-amoxiclav resistance was apparent in Portugal (9.3%) as was resistance to the quinolones, nalidixic acid and ciprofloxacin, in Portugal (11.6% and 5.8%, respectively) and Spain (26.7% and 14.7%, respectively). Overall, Proteus mirabilis were less resistant to ampicillin (16.1%) and more resistant to trimethoprim (25.5%) than E. coli, whereas Klebsiella spp. were more resistant to ampicillin (83.5%) and fosfomycin (56.7%). ‘Other Enterobacteriaceae’ were more resistant to the broad spectrum ß-lactams (ampicillin 45.9%, co-amoxiclav 21.3% and cefadroxil 24.6%), nitrofurantoin (40.2%) and fosfomycin (15.6%). In Staphylococcus saprophyticus resistance development was rare. Overall, antimicrobial resistance was lowest in the Nordic countries and Austria and highest in Portugal and Spain.
* Tel: +46-470-587477; Fax: +46-470-587455; E-mail: gunnar.kahlmeter{at}ltkronoberg.se
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  B. J. Knottnerus, S. Nys, G. ter Riet, G. Donker, S. E. Geerlings, and E. Stobberingh Fosfomycin tromethamine as second agent for the treatment of acute, uncomplicated urinary tract infections in adult female patients in The Netherlands? J. Antimicrob. Chemother., August 1, 2008; 62(2): 356 - 359. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Cagnacci, L. Gualco, E. Debbia, G. C. Schito, and A. Marchese European Emergence of Ciprofloxacin-Resistant Escherichia coli Clonal Groups O25:H4-ST 131 and O15:K52:H1 Causing Community-Acquired Uncomplicated Cystitis J. Clin. Microbiol., August 1, 2008; 46(8): 2605 - 2612. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Higashide, M. Kuroda, C. T. N. Omura, M. Kumano, S. Ohkawa, S. Ichimura, and T. Ohta Methicillin-Resistant Staphylococcus saprophyticus Isolates Carrying Staphylococcal Cassette Chromosome mec Have Emerged in Urogenital Tract Infections Antimicrob. Agents Chemother., June 1, 2008; 52(6): 2061 - 2068. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. K. Olofsson, L. L. Marcusson, A. Stromback, D. Hughes, and O. Cars Dose-related selection of fluoroquinolone-resistant Escherichia coli J. Antimicrob. Chemother., October 1, 2007; 60(4): 795 - 801. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Reeves The 2005 Garrod Lecture: The changing access of patients to antibiotics - for better or worse? J. Antimicrob. Chemother., March 1, 2007; 59(3): 333 - 341. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Qin, Y. Razia, J. R. Johnson, J. R. Stapp, D. R. Boster, T. Tsosie, D. L. Smith, C. R. Braden, K. Gay, F. J. Angulo, et al. Ciprofloxacin-resistant gram-negative bacilli in the fecal microflora of children. Antimicrob. Agents Chemother., October 1, 2006; 50(10): 3325 - 3329. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Nys, T. van Merode, A. I. M. Bartelds, and E. E. Stobberingh Urinary tract infections in general practice patients: diagnostic tests versus bacteriological culture J. Antimicrob. Chemother., May 1, 2006; 57(5): 955 - 958. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. T. Blahna, C. A. Zalewski, J. Reuer, G. Kahlmeter, B. Foxman, and C. F. Marrs The role of horizontal gene transfer in the spread of trimethoprim-sulfamethoxazole resistance among uropathogenic Escherichia coli in Europe and Canada J. Antimicrob. Chemother., April 1, 2006; 57(4): 666 - 672. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Arslan, O. K. Azap, O. Ergonul, F. Timurkaynak, and on behalf of the Urinary Tract Infection Study Gro Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey J. Antimicrob. Chemother., November 1, 2005; 56(5): 914 - 918. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Kuroda, A. Yamashita, H. Hirakawa, M. Kumano, K. Morikawa, M. Higashide, A. Maruyama, Y. Inose, K. Matoba, H. Toh, et al. Whole genome sequence of Staphylococcus saprophyticus reveals the pathogenesis of uncomplicated urinary tract infection PNAS, September 13, 2005; 102(37): 13272 - 13277. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. K. Lindgren, L. L. Marcusson, D. Sandvang, N. Frimodt-Moller, and D. Hughes Biological Cost of Single and Multiple Norfloxacin Resistance Mutations in Escherichia coli Implicated in Urinary Tract Infections Antimicrob. Agents Chemother., June 1, 2005; 49(6): 2343 - 2351. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Landgren, H. Oden, I. Kuhn, A. Osterlund, and G. Kahlmeter Diversity among 2481 Escherichia coli from women with community-acquired lower urinary tract infections in 17 countries J. Antimicrob. Chemother., June 1, 2005; 55(6): 928 - 937. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. M. Hooton, D. Scholes, K. Gupta, A. E. Stapleton, P. L. Roberts, and W. E. Stamm Amoxicillin-Clavulanate vs Ciprofloxacin for the Treatment of Uncomplicated Cystitis in Women: A Randomized Trial JAMA, February 23, 2005; 293(8): 949 - 955. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Sullivan, A. Fianu-Jonasson, B.-M. Landgren, and C. E. Nord Ecological Effects of Perorally Administered Pivmecillinam on the Normal Vaginal Microflora Antimicrob. Agents Chemother., January 1, 2005; 49(1): 170 - 175. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. P. Shannon and G. L. French Increasing resistance to antimicrobial agents of Gram-negative organisms isolated at a London teaching hospital, 1995-2000 J. Antimicrob. Chemother., May 1, 2004; 53(5): 818 - 825. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Kahlmeter, P. Menday, and O. Cars Non-hospital antimicrobial usage and resistance in community-acquired Escherichia coli urinary tract infection J. Antimicrob. Chemother., December 1, 2003; 52(6): 1005 - 1010. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Komp Lindgren, A. Karlsson, and D. Hughes Mutation Rate and Evolution of Fluoroquinolone Resistance in Escherichia coli Isolates from Patients with Urinary Tract Infections Antimicrob. Agents Chemother., October 1, 2003; 47(10): 3222 - 3232. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Kahlmeter and P. Menday Cross-resistance and associated resistance in 2478 Escherichia coli isolates from the Pan-European ECO{middle dot}SENS Project surveying the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections J. Antimicrob. Chemother., July 1, 2003; 52(1): 128 - 131. [Abstract] [Full Text] [PDF]
|
|